- Report
- July 2025
- 131 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- May 2025
- 180 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 190 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- May 2025
- 191 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- July 2025
- 175 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- July 2025
- 285 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 175 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 184 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 482 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 179 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- June 2025
- 140 Pages
Global
From €2717EUR$2,999USD£2,342GBP
- Report
- May 2025
- 112 Pages
Global
From €4303EUR$4,750USD£3,709GBP
- Report
- June 2025
- 120 Pages
United States
From €5390EUR$5,950USD£4,646GBP
- Report
- April 2024
- 293 Pages
Global
From €4347EUR$4,799USD£3,747GBP
- Report
- May 2024
- 535 Pages
Global
From €4484EUR$4,950USD£3,865GBP
- Report
- November 2023
- 30 Pages
Global
From €2944EUR$3,250USD£2,538GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3505EUR$3,869USD£3,021GBP
- Report
- October 2022
- 286 Pages
Global
From €2265EUR$2,500USD£1,952GBP
- Report
- October 2024
- 84 Pages
Global
From €3500EUR$4,139USD£3,122GBP

The Fusion Protein market is a subset of the Drug Discovery market, focusing on the development of fusion proteins for therapeutic use. Fusion proteins are created by combining two or more proteins, which can be used to increase the stability, solubility, and bioavailability of the proteins. Fusion proteins can also be used to target specific tissues or organs, or to increase the half-life of a protein.
Fusion proteins are used in a variety of therapeutic areas, including oncology, immunology, and metabolic diseases. They are also used in the development of vaccines and diagnostics.
Companies in the Fusion Protein market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more